Скачать или смотреть Telix Pharmaceuticals Class Action Lawsuit: Rosen Law Firm Encourages Investors to Act

Rosen Law Firm has filed a class action lawsuit against Telix Pharmaceuticals Ltd. for allegedly misleading investors during the Class Period of February 21 - August 28, 2025. The firm encourages investors who purchased Telix securities during this period to join the class action and seek compensation. The lawsuit claims that Telix made materially false statements regarding their prostate cancer therapeutic candidates and the quality of their supply chain partners.
The Rosen Law Firm has a strong track record in securities class actions, achieving the largest settlement against a Chinese company and being ranked No. 1 by ISS Securities Class Action Services in 2017. Investors are advised to select qualified counsel with a proven success record for leadership roles in such cases.
To join the class action, investors can visit the firm's website or contact Phillip Kim, Esq. for more information. The deadline to move the court for lead plaintiff is January 9, 2026.